Background: Extant research relating to the psychological impact of infectious respiratory disease epidemics/pandemics suggests that frontline workers are particularly vulnerable.Methods: The current study used data from the first two waves of the United Kingdom (UK) survey of the COVID-19 Psychological Research Consortium (C19PRC) Study to compare frontline workers with the rest of the UK population on prevalence estimates of depression, anxiety, and PTSD during the first week of ‘lockdown’ (Wave 1) and one month later (Wave 2).Results: Compared to the rest of the population, frontline workers generally, and individual frontline worker groups, had significantly higher prevalence estimates of depression, anxiety, and PTSD during both wave 1 and wave 2. While prevalence estimates of depression significantly increased among Local & National Government Workers from Wave 1 (15.4%) to Wave 2 (38.5%), no significant improvement or deterioration in mental health status was recorded for any other frontline worker group. Multivariate binary logistic regression analysis showed that, beyond other risk factors, food workers were nearly twice as likely as others to screen positive for anxiety, while all frontline worker groups, other than transport workers, were significantly more likely to screen positive for PTSD (Odds Ratios ranged from 1.74 – 3.43). Finally, while frontline workers, generally, were significantly more likely than the general public to have received mental health advice during the pandemic (26.9% versus 20.3% respectively), this was largely reflective of health and social care workers (37.9%).Conclusions: These findings offer timely and valuable information on the psychological health status of UK’s frontline workforce during the early stages of the COVID-19 pandemic and may aid in preparations for their future psychological and mental health support.
Background
Complex posttraumatic stress disorder (CPTSD) describes the results of complex, prolonged, and/or inescapable trauma, and is typified by avoidance, re-experiencing, sense of threat, affect dysregulation, negative self-concept, and interpersonal disturbances. Additionally, CPTSD is highly comorbid with other common psychopathologies.
Objectives
A study was conducted in a trauma-exposed UK Armed Forces Veteran population resident in Northern Ireland (
N
= 638, NI) to determine the prevalence of CPTSD and comorbid associations.
Methods
Data from the Northern Ireland Veterans Health and Wellbeing Study (NIVHWS), including self-report data describing traumatic stress, depression, anxiety, and suicidality, were used in a latent class analysis to identify distinct profiles of symptomology in the sample, and in a multinomial logistic regression to identify comorbidities associated with class membership.
Results
Three distinct classes emerged: a low endorsement ‘baseline’ class (36%), a ‘Moderate Symptomatic’ class (27%), and a high endorsement ‘Probable CPTSD’ class (37%). Both the Moderate Symptomatic and CPTSD classes were predicted by cumulative trauma exposure. Depression was highly comorbid (
OR
=
.06 in CPTSD), as was anxiety (
OR
=
.05 in CPTSD) and suicidal ideation (
OR
=
.32 in CPTSD), with suicidal attempt associated with the CPTSD class (
OR
=
.51).
Conclusions
Cases of probable CPTSD were more prevalent than cases of probable posttraumatic stress disorder (PTSD) without Difficulties in Self-Organisation (DSO) symptoms in a UK Armed Forces veteran sample, were associated with repeated/cumulative trauma, and were highly comorbid across a range of psychopathologies. Findings validate previous literature on CPTSD and indicate considerable distress and thus need for support in UK Armed Forces veterans resident in NI.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.